Pancreas Cancer Symposium: State-of-the-Art 2018 and Beyond

Pancreas Cancer Symposium: State-of-the-Art 2018 and Beyond Banner


Date & Location
Friday, November 30, 2018, 7:30 AM - 5:30 PM, Zuckerman Research Center 417 E 68th St, New York, NY

Target Audience
Gastrointestinal Oncology, Hematology & Oncology, Hospital Medicine, Internal Medicine , Medical Genetics, Medical Oncology, Nurse Practitioner, Nursing, Pathology, Pharmacy, Physician Assistant, Solid Tumor Oncology, Surgical Oncology, Surgical Pathology

Overview

Pancreas cancer incidence is on the rise. Treatment paradigms are changing and many novel approaches are under development in this disease. This one day course in conjunction with the Center for Pancreas Cancer Research at Memorial Sloan Kettering is very timely and will review the epidemiology, genomic, molecular and pathologic underpinnings of this disease along with discussing diagnostic and therapeutic approaches for localized, locally advanced and metastatic pancreas adenocarcinoma. An emphasis will be on multidisciplinary decision making and will include a case-based focus. The course will also discuss novel treatments under development and where the field is heading.

This course is designed for medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists, pharmacists, nursing, advanced practice practitioners, trainees and other disciplines

In partnership with the David M. Rubenstein Center for Pancreatic Cancer Research

Multidisciplinary Breakout Session | 10:50 am-12:30 pm

This session targets the following providers: Nurses, NP’s, PA’s, Clinical Trial Nurses, Social Workers and Nutritionists. Providers who practice in the Inpatient, Ambulatory Care setting, and clinical trials will benefit. Pancreas cancer presents with many challenges. Patients with pancreas cancer have a unique spectrum of disease and treatment related adverse events which often overlap making care of these patients challenging. Emerging clinical trials with new agents broaden the potential spectrum of toxicities. In this session a multidisciplinary team will address the complex care needs of these patients.



Objectives
  1. Understand the pathologic, genetic and molecular hallmarks of pancreas cancer
  2. Understand the importance of and where to optimally utilize multidisciplinary care for management of pancreas cancer
  3. Outline current diagnostic and surgical strategies for pancreas cancer
  4. Review the indications and implications of germline and somatic testing in pancreas cancer
  5. Define the key novel therapeutic approaches for management of pancreas cancer

Registration

 Registration Type  Early*   General 
 Physicians (MDs, PhDs and DOs)  $275   $325 
 Residents, Fellows, Nurses and Other Healthcare Providers      $125   $175 
 Industry Professionals**  $525   $575 

*Special Early Rate Expiration October 15, 2018
**Industry professionals may attend CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Registration includes continental breakfast, lunch, and refreshment breaks. Please contact us at least one week prior to the course if you have any special dietary needs.

  • 30% Discounted Rate for MSK Alumni and MSK Alliance Members - MSK offers a discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact cme@mskcc.org for more information or to register.
  • MSK Staff Registration - Registration is complimentary for MSK staff. However, you must complete course registration to attend this course. 
After your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course (cme@mskcc.org).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.



Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

MSK designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 Medical Knowledge MOC Points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit

ANCC CE Contact Hours 

Memorial Sloan Kettering Cancer Center - Nursing Professional Development/Continuing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Contact hours will be awarded to participants who attend the program in its entirety and complete a program evaluation. Partial credit not awarded.